About Glenmark Life Sciences
Glenmark Life Sciences is a Mainboard IPO with an issue size of ₹1,513.60 crore, proposed for listing on BSE, NSE. The offer opens on 27th Jul 2021 and closes on 29th Jul 2021. The issue structure includes a fresh issue of ₹1,060.00 crore and an offer-for-sale component of ₹453.60 crore. The current listing schedule points to 6th Aug 2021.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/